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ARTICLE
Super-resolution microscopy reveals functional
organization of dopamine transporters into
cholesterol and neuronal activity-dependent
nanodomains
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Frederik Vilhardt3, Trine N. Jørgensen1, Freja H. Hansen1 & Ulrik Gether 1,2
Dopamine regulates reward, cognition, and locomotor functions. By mediating rapid reuptake
of extracellular dopamine, the dopamine transporter is critical for spatiotemporal control of
dopaminergic neurotransmission. Here, we use super-resolution imaging to show that the
dopamine transporter is dynamically sequestrated into cholesterol-dependent nanodomains
in the plasma membrane of presynaptic varicosities and neuronal projections of dopaminergic
neurons. Stochastic optical reconstruction microscopy reveals irregular dopamine transporter
nanodomains (∼70 nm mean diameter) that were highly sensitive to cholesterol depletion.
Live photoactivated localization microscopy shows a similar dopamine transporter membrane
organization in live heterologous cells. In neurons, dual-color dSTORM shows that tyrosine
hydroxylase and vesicular monoamine transporter-2 are distinctively localized adjacent to,
but not overlapping with, the dopamine transporter nanodomains. The molecular organization
of the dopamine transporter in nanodomains is reversibly reduced by short-term activation of
NMDA-type ionotropic glutamate receptors, implicating dopamine transporter nanodomain
distribution as a potential mechanism to modulate dopaminergic neurotransmission in
response to excitatory input.
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To obtain a detailed understanding of cellular functions andhow they may be altered in disease, it is essential to achieveinsight into the spatial organization of the involved
molecular components and how this architecture is regulated.
The dopamine transporter (DAT), for example, is a key component
of dopaminergic synapses, as it mediates rapid Na+-dependent
reuptake of released dopamine from the terminals and thereby
shapes the spatiotemporal proﬁle of dopamine signaling1, 2.
Consequently, tight control of both DAT distribution and activity
in the dopaminergic neurons are critical for proper regulation
of dopamine homeostasis and thus for governing the role of
dopamine in cognition, reward and locomotor control3.
Mechanisms underlying such regulation become even more
important given that dysfunctional dopamine signaling has been
linked to disorders such as Parkinson’s disease, attention deﬁcit
hyperactivity-disorder, schizophrenia, bipolar disorder, and
drug addiction4. Moreover, DAT is the primary target for
psychostimulants such as cocaine and amphetamines1, 2.
Microscopic techniques have been pivotal for our under-
standing of cellular mechanisms that control the distribution of
individual proteins at the subcellular level. Indeed, several
methods have been applied to visualize DAT, including electron
microscopy (EM)5, 6 and multiple ﬂuorescence microscopy (FM)
approaches5, 7–9. Application of FM has permitted overall insight
into constitutive and regulated trafﬁcking of DAT (for review see
Eriksen et al.10), as well as it has reported abundant and generally
uniform expression of DAT in dopaminergic neurons8, 11. EM
studies similarly support that DAT is widely found in the plasma
membrane of dopaminergic neurons with highest density in the
plasma membrane of the axonal compartment. They also inter-
estingly revealed that the transporter appears to be excluded from
the active zones5, 6. Nevertheless, the important insights from EM
and FM are potentially limited by low antibody labeling efﬁciency
in EM studies, and the restricted resolution of FM. Accordingly,
these approaches may have missed nanoscale heterogeneities in
the subcellular distribution of the transporter that could be
important for spatiotemporal control of its function. In this
context it is interesting that DAT has been suggested to be
sequestered into cholesterol- and glycosphingolipid-enriched
plasma membrane micro domains (“membrane rafts”)12–15, and
that these have been proposed to serve as “hot spots” for reg-
ulation of transporter trafﬁcking and function including
amphetamine-induced dopamine release12, 13.
New super-resolution microscopy techniques offer a major
improvement in the spatial resolution (down to 10 nm in the
lateral direction), thereby enabling visualization of cellular
structures at a resolution unprecedented by conventional ﬂuor-
escent microscopy16–20. Here, we employ photoactivated locali-
zation microscopy (PALM) and stochastic optical reconstruction
microscopy (STORM) super-resolution microscopy to investigate
the nanoscale localization of an endogenously expressed
transmembrane transporter in neurons. STORM imaging of
dopaminergic neurons permitted detailed visualization of DAT
distribution in neuronal projections and presynaptic varicosities.
Remarkably, we ﬁnd that in these structures, DAT is localized
to discrete, irregular, cholesterol-dependent nanodomains. Dual-
color dSTORM imaging demonstrates that the domains are
adjacent to, but not overlapping with, two other key components
of dopaminergic terminals, tyrosine hydroxylase (TH) and vesi-
cular monoamine transporter 2 (VMAT2). Moreover, we provide
evidence that association of DAT to cholesterol-enriched
nandomains is dynamic and conceivably regulated by excitatory
input, as short-term activation of NMDA-type ionotropic gluta-
mate receptors reversibly reduces nanodomain localization of the
transporter. Importantly, the DAT nanodomains are also revealed
by application of STORM or PALM to Cath.a-differentiated
(CAD)21 cells transiently expressing the transporter. Summar-
ized, our data describe a dynamic nanodomain distribution
of DAT that might enable the neuron to rapidly switch the
transporter between different functional localizations and thereby
optimize availability and activity of the transporter on the
nanoscale in the presynaptic terminals.
Results
PALM reveals nanodomain distribution of DAT in CAD cells.
To study the distribution pattern of DAT by single molecule
localization microscopy in live cells we fused the photoswitchable
Dronpa22 to the N-terminus of DAT and expressed the construct
(Dronpa-DAT) in CAD cells. Dronpa-DAT displayed functional
uptake with a Km value similar to wild-type (WT) DAT (Dronpa-
DAT 0.5± 0.2 µM vs. WT 0.5± 0.03 µM, means ± s.e.m., n= 4).
For PALM imaging, the cells were analyzed by total internal
reﬂection microscopy (TIRF-M) enabling imaging of the plasma
membrane facing the glass surface23. The TIRF-M images
themselves showed a strong and diffuse Dronpa-DAT signal with
many scantily resolved areas and a poorly deﬁned cell border
(Fig. 1a). The reconstructed PALM images, however, revealed a
much better resolved Dronpa-DAT signal with a demarcated cell
border characterized by multiple ﬁlapodia-like structures
(Fig. 1b). Corresponding to the plasma membrane adjacent to the
glass surface, we observed that the detected localizations fro
Dronpa-DAT often formed irregular clusters or “nanodomains”
of various sizes as clearly seen when enlarging a region of the
image (Fig. 1c, examples indicated by red arrows). Application of
a density-based spatial clustering of applications with noise
(DBSCAN) analysis, which has been used to assess clustering of
other membrane proteins33, 34, substantiated a clear nanodomain
pattern for DAT with a median cluster size of ~ 70 nm in dia-
meter (Fig. 1d). Importantly, by application of the analysis
recently published by Baumgart et al.24, we could rule out that
these clusters are not the result of multiple observations of single
ﬂuorophores (Supplementary Fig. 1).
We next tested whether the nanodomain distribution seen for
Dronpa-DAT was a general phenomenon for any membrane-
associated protein. We analyzed Src15-Dronpa, consisting of the
myristoylated N-terminus of p60SRC fused to Dronpa. This
protein has been used as a marker of homogenous, non-raft
plasma membrane25 and, in contrast to Dronpa-DAT, the PALM
images revealed a much more homogenous distribution of the
detected localization with a signiﬁcant lower fraction of
localizations in nanodomains (Fig. 1e–h, q). To investigate
the nature of the Dronpa-DAT nanodomains, we extracted
cholesterol from the plasma membrane using 5 mM methyl-β-
cyclodextrin (mβCD)26 or disrupted the actin polymerization
with 5 μg ml−1 cytochalasin D (CytD). The TIRF-M revealed no
apparent effect of mβCD on the Dronpa-DAT distribution;
however, from the reconstructed PALM images and the DBSCAN
quantiﬁcation, we observed a more homogenous distribution of
Dronpa-DAT and a clear reduction in the number of conﬁned
nanodomains (Fig. 1i, j, q). In contrast, CytD did not cause any
apparent changes in the distribution of the Dronpa-DAT signal
(Fig. 1m–q). As determined by a reversible biotinylation assay27,
the mβCD treatment had no effect on Dronpa-DAT internaliza-
tion, indicating that the decreased nanodomain distribution was
not caused by redistribution of the transporter away from the
plasma membrane (Supplementary Fig. 2). To further conﬁrm
the role of cholesterol in the nanodomain distribution of Dronpa-
DAT, we treated the Dronpa-DAT expressing CAD cells with
nystatin, a cholesterol-binding polyene antibiotic, which can
sequester cholesterol in the membrane and disrupt membrane
rafts28. The PALM images showed that nystatin, like mβCD,
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Fig. 1 Dronpa-DAT distributes to cholesterol-dependent nanodomains in the plasma membrane of living CAD cells. a–d Images of untreated live CAD cells
transiently expressing Dronpa-DAT. a TIRF-M image. b Reconstructed PALM image. c Enlarged PALM image corresponding to the boxed region in a, b.
d DBSCAN-based cluster map of Dronpa-DAT distribution. Clustered localizations are shown by color-coding with non-clustered localizations in gray.
e–h Images of live CAD cells expressing the myristoylated N-terminus of p60SRC fused to Dronpa (Src15-Dronpa). e TIRF-M image, f reconstructed PALM
image. g Enlarged PALM image corresponding to the boxed region in e, f. h DBSCAN-based cluster map of Src15-Dronpa distribution. Clustered
localizations are shown by color-coding with non-clustered localizations in gray. i–l Images of Dronpa-DAT expressing CAD cells treated with 5 mM
methyl-β-cyclodextrin (mβCD) to remove cholesterol. i TIRF-M image, j reconstructed PALM image. k Enlarged PALM image corresponding to the boxed
region in i, j. i DBSCAN-based cluster map of Dronpa-DAT distribution. m–p Images of Dronpa-DAT expressing CAD cells treated with 5 μg ml−1
cytochalasin D (CytD) to disrupt the actin skeleton. m TIRF-M image, n reconstructed PALM image. o Enlarged PALM image corresponding to the boxed
region in m, n. p DBSCAN-based cluster map of Dronpa-DAT distribution. q Clustering of Dronpa-DAT measured as the fraction in % of total localizations
(means± s.e.m., *p< 0.05, one-way ANOVA with a Bonferroni’s post-test). Data are based on 12–20 cells from three independent experiments. Red arrows
mark examples of DAT clustered in nanodomains. Scale bars a, b, e, f, i, j, m, n 5 μm, c, d, g, h, k, l, o, p 1 μm
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caused a signiﬁcant decreased in the fraction of Dronpa-DAT in
nanodomains (Supplementary Fig. 3).
The marked effect of cholesterol depletion on DAT distribution
prompted us to test biochemically whether DAT expressed in
CAD cells is distributed into detergent-resistant membrane
fractions (i.e., the membrane raft fractions) in a cholesterol-
dependent manner. CAD cells transiently expressing DAT were
extracted with the non-ionic detergent Brij 58 and subjected to
sucrose density gradient fractionation. Western blotting analysis
of the resulting fractions showed that DAT was distributed in part
to the detergent-resistant high buoyancy fractions identiﬁed by
ﬂotillin-1 (FLOT-1), a marker of membrane rafts29 (Supplemen-
tary Fig. 4a). DAT immunoreactivity was also, as expected, found
in the high-density fractions identiﬁed by the transferrin receptor
(TfR) (Supplementary Fig. 4a). In correspondence with our
PALM analysis, cholesterol depletion with mβCD prior to cell
lysis, removed DAT immunoreactivity from the detergent-
resistant high buoyancy fractions, whereas CytD had no effect
(Supplementary Fig. 4a). Of note, endogenous DAT solubilized
from striatal extracts also distributed in part to the detergent-
resistant high buoyancy fractions (Supplementary Fig. 4b).
STORM also shows nanodomain distribution of DAT in CAD
cells. To demonstrate that the observed nanodomain distribution
of DAT in CAD cells is not a result of fusing Dronpa to the
N-terminus of the transporter, we also imaged DAT in CAD cells
using STORM. STORM is based on immunolabeling with
ﬂuorophore-conjugated antibodies and therefore permits visua-
lization of a target protein without having it fused to ﬂuorescent
proteins17. DAT expressing CAD cells were permeabilized and
immunolabeled with a rat monoclonal antibody targeting the
DAT N-terminus, followed by labeling with Alexa405 and
Alexa647 conjugated secondary antibodies. Equivalent to what we
observed for Dronpa-DAT, the STORM images revealed locali-
zations that often formed irregular nanodomains that were not
discernible in the TIRF-M images (Fig. 2a–d). Indeed, a DBSCAN
analysis of the STORM data conﬁrmed DAT clustering in the
plasma membrane of the CAD cells (Fig. 2e, k) and showed that
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Fig. 2 Visualization of DAT by STORM in CAD cells. TIRF-M (a, c, f, h), STORM (b, d, g, i, m, o), and wideﬁeld (l, n) images of CAD cells transiently
expressing DAT with or without cholesterol depletion with 5mM mβCD. DAT was visualized by immunolabeling with primary DAT antibody and
Alexa405-Alexa647 conjugated-anti-rat secondary antibody. a, f TIRF-M view of DAT with (mβCD) or without cholesterol depletion (control).
b, g Reconstructed STORM image of TIRF-M image in a or f. c, d, h, i Enlarged TIRF-M or STORM images corresponding to the boxed regions in a, b
(control) or f, g (mβCD). e, j DBSCAN-based cluster map of the STORM images in d (control) and j (mβCD). Clustered localizations are shown by
color-coding with non-clustered localizations in gray. k Fraction of particles (according to DBSCAN) clustered in nanodomains with (mβCD) or without
cholesterol depletion (control). Data are % of localizations in cluster (means± s.e.m., *p< 0.05, unpaired two-tailed t-test). l–o Visualization of DAT
expressing CAD cells using inclined illumination to visualize a cross section through the cell. lWideﬁeld image,m reconstructed STORM image of wideﬁeld
image in l, n, o Enlarged TIRF-M or STORM images corresponding to the boxed regions in l, m. Red arrows mark DAT clustered in nanodomains. Data are
based on 14–16 cells from three independent experiments. Scale bars a, b, f, g, l, m 5 μm, c–e, h–j 500 nm, n, o 400 nm
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cholesterol depletion decreased the estimated fraction of DAT in
clusters (Fig. 2f–k).
In addition to TIRF-M illumination, we also performed
STORM on the CAD cells with inclined illumination enabling
visualization of a cross section through the cell. This imaging
protocol is especially important when imaging neurons that may
not have larger surfaces adhering directly to the glass surface as
required for useful TIRF-M data. The use of inclined illumination
supported the same distribution pattern of DAT in CAD cells as
that observed with TIRF-M illumination; that is, the recon-
structed STORM images revealed a DAT immunosignal dis-
tributed into discrete well-deﬁned but irregularly shaped
nanodomains of various sizes along the plasma membrane
(Fig. 2l–o).
DAT is localized to nanodomains in dopaminergic neurons. To
assess the distribution of endogenously expressed DAT, we pre-
pared cultures of dopaminergic neurons and employed a STORM
protocol similar to that used for the CAD cells. By wideﬁeld
microscopy, using inclined illumination to reduce background
signal, we observed a diffuse DAT immunosignal in the neuronal
somas with some larger clusters of intensiﬁed signal (Fig. 3a, b).
The reconstructed STORM images showed a substantially better
resolution with an overall uniform punctate distribution of the
DAT signal, which is likely to represent DAT in various intra-
cellular compartments, as we focus on a thin slice through the
large dopaminergic soma (Fig. 3f, g). In general, we were unable
to see a clear plasma membrane immunosignal in the somas,
consistent with relatively low somatic plasma membrane levels of
DAT and high levels of intracellular DAT5. Interestingly, we also
observed round, often hollow, DAT-positive structures in the
cytosol of the cell bodies with diameters of 100–200 nm (and thus
of the same size as, e.g., clathrin-coated vesicles30), which could
represent DAT-containing vesicles with the N-terminal tail and
thus the antibody–ﬂuorophore complex on the outside of the
vesicle exposed to the cytosol (Fig. 3c, h).
In the network of neuronal extensions and varicosities along
these extensions, the wideﬁeld images showed a strong DAT
immunosignal that was relatively uniformly distributed with
some clustered elements (Fig. 3d, e). The STORM images again
revealed a more punctate DAT distribution with multiple discrete
clusters along the extensions as well as in the varicosities, believed
to equivalent to presynaptic transmitter release sites given the
enriched presence of VMAT28 (Fig. 3i, j). These clusters are likely
to represent DAT conﬁned to nanodomains in the plasma
membrane as the images often indicated two apparent, separated
membrane sheets in the extensions (Fig. 3j). As an example, the
cross-sectional line scan in Fig. 3k reveals a distance of ~ 125 nm
between the two sheets shown in Fig. 3j.
A closer look at the extensions and varicosities showed that the
DAT signal was clustered in irregular nanoscale domains
remarkably similar to those observed by STORM and PALM in
CAD cells with a median cluster size of ~70 nm in diameter
(Fig. 3l, n). A DBSCAN analysis substantiated the strong DAT
clustering in nanodomains along extensions and varicosities
(Fig. 3m, o, p). The nanodomain distribution was further
supported by a nearest-neighbor analysis31. If DAT is homo-
genously expressed, then the resulting artifact clusters would be of
uniform density because the photoswitching is constant within in
the image. However, the individual clusters did not have a
uniform density but rather became denser at the center, strongly
supporting a truly clustered distribution (Fig. 3q–t).
DAT nanodomain localization is cholesterol-dependent. To
investigate if cholesterol also had an effect on endogenous DAT
distribution, neurons were treated with mβCD before STORM
imaging. Similar to what we observed in CAD cells, mβCD
decreased the clustered distribution of the DAT localizations in
both neuronal extensions and varicosities (Fig. 4a–h). This was
supported by DBSCAN analysis showing a signiﬁcant reduction
in the fraction of DAT in clusters (Fig. 4m, n). Moreover, the
mβCD treatment decreased the size of the clusters, as illustrated
by plotting the cumulative cluster distribution as a function of
cluster area (Fig. 4o, p). In contrast to cholesterol depletion,
disruption of the cytoskeleton with CytD before ﬁxation had no
effect on DAT distribution. (Fig. 4i–p). We also tested the effect
of nystatin and, as in the CAD cells, we observed a decrease in
DAT clustering further supporting a key role of cholesterol
(Supplementary Fig. 5). The reduced clustering upon cholesterol
depletion/sequestration was unlikely caused by redistribution of
DAT away from the membrane. That is, we saw no change in the
constitutive internalization of DAT in response to mβCD treat-
ment, as determined by quantifying intracellular accumulation of
DAT labeled with the ﬂuorescent cocaine analog JHC 1-6432
(Supplementary Fig. 6). Note that JHC 1-64 only visualizes sur-
face DAT and internalized DAT, and not the large total pool of
cytosolic DAT seen in the STORM images. As a consequence, the
amount of DAT present on the cell surface might be less apparent
in the STORM images compared to the JHC 1-64 confocal
images.
NMDA receptor activation reduces DAT nanodomain localization.
We next tested whether the nanodomain distribution of DAT was
subject to dynamic regulation. Dopaminergic neurons are tightly
regulated by excitatory input via ionotropic glutamate receptors.
For example, a single dose of cocaine can elicit NMDA-receptor-
dependent long-term potentiation (LTP) at midbrain glutama-
tergic synapses onto dopaminergic neurons33, 34. Moreover, there
is evidence for the presence of NMDA receptors on the axonal
terminals of these neurons, and direct short-term stimulation
(5 min) of the neurons with NMDA can increase burst ﬁring35, 36.
We stimulated accordingly our cultured neurons either with
NMDA alone (20 µM) or together with the selective NMDA
receptor antagonist AP5 (100 µM), before STORM imaging.
Strikingly, the resulting STORM images showed a signiﬁcant
decrease in DAT nanodomain localization in response to NMDA
in both extensions and varicosities. This effect was blocked by
AP5, in agreement with a speciﬁc effect on the NMDA receptors
(Fig. 5a–p). There was no effect on the cluster size in the
extensions, however, in the varicosities the NMDA treatment,
similar to the mβCD treatment, decreased the cluster size of DAT
(Fig. 5o, p). Subsequently, we tested whether the effect was
reversible, that is, we assessed whether a 1-h recovery period
following the 5-min NMDA treatment would reverse the change
in DAT distribution. Again, in this experiment when neurons
were ﬁxed immediately after NMDA treatment, we reproduced
the clear reduction in DAT clustering compared to the untreated
neurons. However, when the dopaminergic neurons were allowed
to recover for 1 h after NMDA washout, DAT recovered the
degree of clustering seen in the untreated cells (Fig. 5q). Hence,
NMDA appears to dynamically regulate DAT clustering in a
reversible manner.
DAT displays non-overlapping distributions with TH and
VMAT2. We ﬁnally wanted to apply dual-color dSTORM ima-
ging to compare the distinct distribution of DAT with other key
proteins of dopaminergic neurons. First, we evaluated the labeling
accuracy by dual-labeling DAT with two separate ﬂuorophores
species in the same sample, Alexa647 and CF568. For this dual
labeling, we observed that, although a greater number of locali-
zations was detected with Alexa647, many of the detections from
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-00790-3 ARTICLE
NATURE COMMUNICATIONS |8:  740 |DOI: 10.1038/s41467-017-00790-3 |www.nature.com/naturecommunications 5
Extension
k
125 nm
0
20
40
60
80
100
p n
Extension
l
Varicosity
STORM Cluster map
Distance (μm)
o
m
Varicosity
a
b,g
c,h
Soma
b
Soma edge
d
Extensions
varicosity
Extensions
varicosity
e
S
T
O
R
M
W
id
ef
ie
ld
g if
b,g
c,h
h j
c
Vesicle
Varicosity
q r s t
r
s
t
0.0 0.50.40.30.20.1
20
0
40
60
80
100
G
ra
y 
va
lu
es
 A
.U
.
F
ra
ct
io
n 
in
 c
lu
st
er
 (
%
)
80
70
60
50
40
30
20
10
80
70
60
50
40
30
20
10
80
90
70
60
50
40
30
20
10
0
60 40
35
30
25
20
15
10
5
0
420
400
380
360
340
320
300
280
260
66
0
64
0
62
0
60
0
58
0
56
0
54
0
52
0
50
0
50
40
30
20
10
0
1200
1150
1100
1050
1000
950 0 50
100 150
200
1750
1700
1650
1600
1550
1500 600 650
700 750
800 850
54
48
42
36
32
28
24
20
16
12
8
30
24
18
12
6
***
***
Soma Varicosity Extension
Fig. 3 Endogenous DAT is clustered in nanodomains in the extensions and varicosities of cultured dopaminergic neurons. a–c, f–h Cross-section views
through dopaminergic cell body showing the DAT distribution in the soma in an overall view, the soma edge, and in intracellular vesicular structures. DAT
was visualized by immunolabeling with primary DAT antibody and Alexa405-Alexa647-conjugated secondary antibody. a, f Wideﬁeld image and
corresponding reconstructed STORM image in the cell body. b, g Wideﬁeld image and corresponding STORM image at the soma edge; c, h Enlarged
wideﬁeld or STORM image corresponding to the boxed regions in a, f, visualizing DAT in a putative endocytic vesicle. Yellow arrows highlight the circular
distribution of the DAT signal. d, i Wideﬁeld image and reconstructed STORM image in a representative extension with varicosities. e, j Enlarged wideﬁeld
image and corresponding STORM image of extension and varicosity. k Cross sectional proﬁle along the boxed region in j showing the signal intensity as a
function of the distance (µm). l, m STORM image and corresponding DBSCAN-based cluster map showing the degree of clustering of DAT in a
representative varicosity. n, o STORM image and corresponding DBSCAN-based cluster map showing the degree of clustering of DAT in a representative
extension. Clustered localizations are shown by color-coding with non-clustered localizations in gray. p DBSCAN-based quantiﬁcation of the clustering
of endogenous DAT in dopaminergic neurons in soma, varicosities and extensions. Data are % of localizations in cluster (means± s.e.m., ***p< 0.001,
one-way ANOVA and Bonferroni’s post-test). Data are from 16 to 32 images from six individual experiments. Red arrows mark DAT clustered in
nanodomains. q Varicosity from image n, where the localizations are colored by the number of nearest neighbors within a 30 nm radius. r–t Example
clusters of varied densities identiﬁed in image q, where the number of nearest neighbors within a 30 nm radius are identiﬁed by color and by position on the
z axis. Scale bars a, f, l 5 μm, b, d, g, i 1 μm, c, h, m 200 nm, e, j, n–q, s 500 nm
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the two ﬂuorophore species identiﬁed the same groups of DAT.
This applied both to somas, where DAT appeared to be mainly in
the cytosolic compartment, as also seen for the single color
dSTORM images of DAT, and to extensions and varicosities,
where DAT nanodomains along the presumed membrane
were clearly resolvable (Supplementary Fig. 7). Importantly,
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a quantitative co-localization analysis further supported the
overall strong overlap in labeling between the two ﬂuorophores
(Supplementary Fig. 7).
Tyrosine hydroxylase is the rate-limiting enzyme in dopamine
synthesis and an abundant protein in dopaminergic neurons.
Dual-color dSTORM, targeting DAT and TH with Alexa647 and
CF568, respectively, clearly revealed distinct patterns of distribu-
tion for the two proteins. In the cytosol of cell bodies, the DAT
and TH signals were separated with very modest, if any, overlap
(Fig. 6a–f). In the extensions, a punctate appearance of the TH
signal was found between the membrane sheets demarcated by
the DAT signal (Fig. 6g–l). Corresponding to the varicosities, we
observed a strong TH signal unequally distributed in the
presumed cytosol, sometimes forming larger conﬂuent areas
while at the same excluding other areas. Again, the TH signal was
not overlapping with DAT, but, was often seen immediately
adjacent to the conceivably plasma membrane located DAT
(Fig. 6m–o).
The vesicular monoamine transporter (VMAT2) sequesters
monoamines, including dopamine, into synaptic vesicles4. Dual-
color dSTORM targeting DAT and VMAT2 showed that in the
somatic cytosol both proteins were relatively uniformly distrib-
uted, although the VMAT2 localizations appeared in larger
groups compared to DAT. Neither DAT nor VMAT2 appeared to
strongly accumulate in the somatic plasma membrane and,
strikingly, we saw essentially no overlap between the two proteins,
supporting differential cellular sorting of the two membrane
proteins (Fig. 7a–f). In the neuronal processes, the VMAT2 signal
was markedly enriched in the varicosities (and thus at the
presumed presynaptic release sites) with some localization to the
extensions where a punctate signal was present between the two
apparent membrane sheets deﬁned by the DAT distribution
(Fig. 7g–i). Corresponding to the varicosities, the strong
VMAT2 signal often appeared almost conﬂuent in the cytosol,
though in other cases a clear polarization of signal was observed.
The VMAT2 signal in varicosities was sometimes found to reside
in immediate vicinity of a large population of DAT, but there was
very little overlap in the signals (Fig. 7g–o). Altogether, these
dual-color experiments substantiate the differential distribution
pattern at sub-diffracting resolution of three key components of
the dopaminergic presynapse.
Discussion
Visualization of cellular processes is of fundamental importance
to gain insight into complex biological systems. Indeed,
visualization with classical FM has proven its value when study-
ing many cellular processes, such as those governing targeting
and trafﬁcking of receptors, transporters and ion channels in
different cell types. Nonetheless, the diffraction-limited resolution
obtainable with conventional FM has prevented visualization of
small cellular structures with sizes in the lower nanometer range,
and thereby hindered a detailed dissection of the molecular
distribution of membrane protein on the nanoscale and how this
is regulated. With the advent of super-resolution microscopy,
permitting ﬂuorescent imaging at subdiffraction resolution,
a substantial part of these obstacles has been overcome, as illu-
strated by the application of this technique to DAT in the present
study. Although EM still offers superior resolution, technical
difﬁculties and requirements for sample preparation challenge the
applicability of EM when testing the effect of pharmacological
and biochemical manipulations. Speciﬁcally, the low labeling
efﬁciency of immunogold EM imaging makes the technique less
suitable for investigating protein clustering in a quantitative
manner37.
In this study, we apply super-resolution microscopy to reveal
and visualize a dynamic molecular distribution of DAT in
dopaminergic neurons. Speciﬁcally, the super-resolution images
revealed that DAT is not uniformly distributed in the plasma
membrane, as seen with classical microscopy8, 11, 38, but localized
to multiple irregular clusters or “nanodomains”. The nanodo-
mains were clearly seen in the neuronal extensions where they
demarcated two separate membrane sheets only 100–150 nm
apart, as well as they were strongly present in the varicosities that
presumably represent presynaptic transmitter release sites8.
Corresponding to the cell bodies of the cultured neurons, we
observed little apparent DAT signal in the plasma membrane, but
a strong cytoplasmic DAT signal that may represent newly syn-
thesized DAT in the ER and Golgi in agreement with previous
ﬁndings5.
The DAT nanodomains in the extensions and varicosities of
the dopaminergic neurons were also seen upon expression of
DAT in catecholaminergic CAD cells. In the CAD cells, the DAT
nanodomains were visualized both by STORM, as in the neurons,
and by PALM. Whereas STORM and dSTORM exploit secondary
antibody-ampliﬁcation together with a photoswitchable multi-
emitter ﬂuorophore, PALM is based on use of photoswitchable
ﬂuorescent protein fused to the protein of interest, in this case,
Dronpa fused to DAT. PALM can accordingly be performed on
live cells without ﬁxation and permeabilization. Moreover, the
1:1 stochiometry between the ﬂuorescent protein and the target
protein abolishes putative artifacts derived from having more
than one or less than one ﬂuorophore attached to the target
protein17. The need for using a fusion protein in PALM prevents
analysis of endogenously expressed proteins17. STORM/
dSTORM, on the other hand, excels by allowing investigation of
endogenously expressed proteins, but typically requires ﬁxation
and, if the epitope is intracellular, permeabilization37. Impor-
tantly, we observed nanodomain distribution of DAT with
STORM in the CAD cells as we did with live PALM, suggesting
that ﬁxation and permeabilization are not a problem for our
observations. We should note, however, that that the apparent
fraction of DAT in clusters was higher according to our STORM
data than in our PALM data. A conceivably explanation for this
apparent discrepancy might relate to differences in the amount of
blinking per ﬂuorophore and the stoichiometry of the ﬂuor-
ophores to transporter, which in the DBSCAN analysis may lead
to a higher estimated clustered fraction in STORM compared to
PALM.
The conﬁnement of DAT into nanodomains displayed a
striking dependency on cholesterol. Both removal of cholesterol
with mβCD or sequestering cholesterol with nystatin markedly
reduced DAT nanodomain localization in neurons and CAD
cells. This observation is not least interesting because the high-
resolution structure of Drosophila DAT revealed a cholesterol-
binding site on the surface of the transporter39. In addition,
cholesterol has been shown to regulate DAT function14, 15, 40 as
well as the lateral mobility of heterologously expressed DAT in
the plasma membrane13, 14. It is thus tempting to suggest that
cholesterol-dependent sequestration of DAT into nanodomains
represents a spatial correlate of function governed by direct
binding of cholesterol to the transporter. The inﬂuence of cho-
lesterol on DAT nanodomains is moreover of interest in light of
previous biochemical data, as well as biochemical data from this
study, indicating that DAT, in heterologous cells and striatal
tissue, segregates into detergent-resistant membrane fractions
(membrane raft factions) dependent on cholesterol12, 14, 15. The
nanodomain distribution of DAT could also have important
implications in relation to ﬁndings suggesting that localization of
DAT to membrane cholesterol-dependent rafts is important for
amphetamine-induced dopamine efﬂux via DAT12, 41 and for
regulation of transporter internalization15. Even more intriguing
and with potentially larger functional implications, we found that
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the cholesterol-dependent nanodomain distribution of DAT is
sensitive in a reversible manner to activation of excitatory
receptors, such as NMDA receptors. NMDA receptor activation
on dopaminergic neurons is known to increase burst ﬁring43, 44
and, on this background, it is tempting to suggest that reversible
association to cholesterol-dependent nanodomains might repre-
sent a means by which the neuron rapidly can adjust transporter
localization and availability on the nanoscale in order to adapt to
neuronal activity.
Previous biochemical data have suggested a tight association
between DAT, TH and VMAT2 containing synaptic vesicles42, 43.
For example, it has been proposed that DAT and VMAT2 are
physically linked together via the synaptic vesicle protein
synaptogyrin-343. To our knowledge, the relative distribution of
these proteins, however, has never been investigated at sub-
diffracting resolution. Importantly, the present dual-color super-
resolution experiments demonstrate a distribution of DAT that is
clearly distinct from that of both VMAT2 and TH. TH, the rate-
limiting enzyme in dopamine synthesis, showed an irregular
distribution in the cytosol of both extensions and varicosities. In
the varicosities, the clustered signal was often found immediately
adjacent to, but not overlapping with, the DAT nanodomains.
This supports close proximity, but not formation of larger co-
complexes. For VMAT2, we found a strongly enriched signal in
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Fig. 6 Cross-section through the cell body, extensions and varicosities of
dopaminergic neurons showing by dual-color dSTORM imaging the distinct
distribution of tyrosine hydroxylase (TH) compared to DAT. DAT was
visualized by immunolabeling and Alexa647-conjugated secondary
antibody. TH was visualized by immunolabeling and CF568-conjugated
secondary antibody. a Somatic distribution of DAT. b Somatic distribution
of TH. c Merged image of a and b. d–f Enlarged STORM images
corresponding to the boxes shown in a–c. g Distribution of DAT in
extension with varicosity. h Distribution of TH in extension with varicosity.
iMerged image of g and h. j Distribution of DAT in extension. k Distribution
of TH in extension. l Merged image of j and k. m Distribution of DAT in
varicosity. n Distribution of TH in varicosity. o Merge image of m and n.
Scale bars: a–c 5 μm, g–i 2 μm, d–f, j–o 500 nm
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Fig. 7 Cross-section through the cell body, extensions and varicosities of
dopaminergic neurons showing by dual-color dSTORM imaging the distinct
distribution of the vesicular monoamine transporter-2 (VMAT2) compared
to DAT. DAT was visualized by immunolabeling and Alexa647-conjugated
secondary antibody. VMAT2 was visualized by immunolabeling and
CF568-conjugated secondary antibody. a Somatic distribution of DAT.
b Somatic distribution of VMAT2. c Merged image of a and b. d–f Enlarged
STORM images corresponding to the boxes shown in a–c. g Distribution of
DAT in extension with varicosities. h Distribution of VMAT2 in extension
with varicosities. i Merged image of g and h. j Distribution of DAT in
extension. k Distribution of VMAT2 in extension. lMerged image of j and k.
m Distribution of DAT in varicosity. n Distribution of VMAT2 in varicosity.
o Merge image of m and n. Scale bars a–c 5 μm, g–i 2 μm, d–f, j–o 500 nm
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the varicosities with limited signal in the extensions, consistent
with the varicosities representing presynaptic release sites. We
also observed that the VMAT2 signal was more uniform than the
TH signal in the varicosities and in several cases “polarized”, i.e.,
the signal was localized essentially to only one part of the var-
icosity. Nonetheless, similar to what we saw for TH, the
VMAT2 signal was often immediately adjacent to, but again, not
overlapping with the DAT signal, arguing against formation of
larger co-complexes.
Still relatively few studies have exploited super-resolution
microscopy to visualize neuronal membrane proteins31, 44–53 and,
to our knowledge, no other study has reported sequestration of an
endogenously expressed neuronal membrane protein into
cholesterol-sensitive nanodomains that might be sensitive to
excitatory input via activation of, e.g., NMDA-receptors.
Application of STORM has allowed a description of how e.g.
ionotropic glutamate receptors themselves as well as metabo-
tropic GABA receptors are positioned in the pre- and post-
synapse44–48. Super-resolution techniques have also suggested
compartmentalized distribution of several membrane proteins
into nanodomains31, 50, 54–57 as well as formation of super-
complexes of ion channels52. AMPA receptors were found to
cluster in spines46 and to be enriched in dynamic nanoscale
scaffolding domains of PSD-9557. It has also suggested that the
SNARE protein syntaxin 1 is sequestered in distinct nanoscale
clusters in the Drosophila neuro-muscular junctions and in het-
erologous PC12 cells but it was not assessed whether the clusters
were dependent on cholesterol and/or the cytoskeleton31, 54. Yet
other neuronal membrane proteins may not cluster such as the
cannabinoid CB1 receptor, adopting a uniform presynaptic dis-
tribution in GABAergic interneurons50.
In summary, the present study demonstrates the power of
super-resolution microscopy to dissect the distribution of an
important membrane transport protein in neurons. Speciﬁcally,
we were able to visualize in detail how DAT is dynamically
sequestered into irregular nanodomains in cellular structures,
such as presynaptic varicosities, which cannot be efﬁciently
resolved by classical FM due their small size. By revealing a
striking cholesterol dependency and sensitivity to excitatory
input, our results introduce new means by which DAT function
can be regulated by membrane lipids and neuronal activity on the
nanoscale. Furthermore, our data represent an important fra-
mework for future studies aimed at further dissecting the
dynamic molecular architecture of dopaminergic neuro-
transmission and how this might change in diseases characterized
by dysfunction of the dopamine system.
Methods
DNA constructs. Dronpa was a kind gift from Dr. Atsushi Miyawaki Brain Science
Insitute, RIKEN, Japan58. EGFP was cut out or the pEGFP-C1 vector (Clontech),
using AgeI and BsrGI, and replaced with a PCR fragment encoding Dronpa to
generate pDronpa-C1 (sense primer:TCCGCTAGCGCTACCGGTCGCCACCA
TGAGTGTGATTAAACCAG; antisense primer:ACTTGTACAGCTTGGCCTG
CCTCGGCAGC). Subsequently, hDAT was subcloned from pcDNA3.1 into the
KpnI and XbaI sites of the pDronpa-C1 generating pDronpa-DAT. The construct
was veriﬁed by sequencing. Src15-Dronpa, consisting of the myristoylated
N-terminus of p60SRC fused to Dronpa was synthesized by DNA 2.0 (Menlo Park,
CA). For sucrose gradient fractionation experiments, we used hDAT encoded by a
synthetic gene kindly provided by Dr. Jonathan Javitch, Columbia University,
NY, USA59.
Cell culture. CAD (purchaseable from Sigma, 08100805) cells were grown in
media containing Ham’s F12 and DMEM (1:1) (GIBCO, Grand Island, NY) and
10% (w/v) fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA) and 1% (v/v)
penicillin/streptomycin (v/v), in 5% CO2 and 95% humidiﬁed atmosphere at 37 °C.
Cells were transiently transfected 48 h prior to experiments in a 1 µg:3 µl Lipo-
fectamine 2000 (Invitrogen) ratio according to manufacturer’s protocol. The cells
were regularly tested for mycoplasma with a standard mycoplasma test kit (Lonza,
NJ, USA).
Dopamine uptake. One day prior to the experiment, 100,000 transiently trans-
fected CAD cells were seeded in 24 well plates (TPP, Trasdingen Switzerland). On
the day of the experiment, the cells were preincubated for 10 min in a HEPES
buffered saline (HBS) (25 mM HEPES, 120 NaCl, 5 mM KCl, 1.2 mM CaCl2, 1.2
mM MgSO4, 1 mM ascorbic acid, 5 mM D-glucose and 1 µM Ro 41-0960 (COMT
inhibitor) pH 7.4. Subsequently the cells were incubated for 3 min at room tem-
perature with a serial dilution from 6.4 to 0.05 µM 3H-DA (2,5,6,7,8-[3H]-DA
52.8–61.4 Ci mmol−1, PerkinElmer Life and Analytical Sciences, Boston, MA).
Uptake was measured using Optiphase HiSafe 3 scintillation ﬂuid (PerkinELmer
Life and Analytical Sciences).
Dissection and culturing of dopaminergic neurons. Dopaminergic neurons from
the ventral midbrain were isolated using a protocol modiﬁed from Rayport et al.60.
The ventral tegmental area and substantia nigra were located and isolated from
P1 to P2 Wistar rats (Charles River, Germany) and dissolved in a papain solution
(116 mM NaCl, 5.4 mM KCl, 26 mM NaHCO3, 2 mM NAH2PO4, 1 mM MgSO4,
EDTA, 25 mM glucose 1 mM cysteine, 0.5 mM Kyrunate, and Papain 20 Uml−1)
for 25 min at 37 °C. The tissue was gently triturated to a single cell suspension by
mechanical force and spun for 10 min at 100 × g, and seeded in warm SF1C [50%
(v/v) modiﬁed Eagle’s medium (MEM), 40% (v/v) Dulbecco’s modiﬁed eagles
medium (DMEM), 10% (v/v) F-12 (all from Invitrogen) supplemented with 1%
(v/v) heat inactivated calf serum (FBS, 2.5 mgml−1, Invitrogen), 0.35% (w/v)
D-glucose, 0.5 mM glutamine, 5 mM Kyrunic acid, Penicillin, Streptomycin, liquid
catalse (0.05%), and DiPorzio61 (containing insulin, transferrin, superoxide dis-
mutase, progesterone, cortisol, Na2SeO3, and T3)] on Poly-D-Lysine coated, 1 M
KOH sonicated coverslips with a thickness of 160–180 µm for STORM imaging or
on a glia cell monolayer on coverslips for internalization experiments. Two hours
after seeding, the cells were treated with 10 ng ml−1 glia derived neurotrophic factor
(GDNF). 5-Fluorodeoxyurdine was added to the cell media at 6–7 DIV in order to
inhibit cell proliferation of glia cells. The sample was used after 8–11 DIV.
Antibody labeling. Antibodies were labeled using a protocol described in Bates
et al.62. The antibody (63 μg) was incubated for 40 min while shaking at room
temperature with 100 mM NaHCO3, Alexa647 (17 μg ml−1), Alexa405 (50 μg ml−1)
(Invitrogen, Carlsbad, Germany), or CF568 (Biotium, Freemont, CA) in a total
volume of 60 µl in PBS and afterwards mixed with 140 μl PBS on a NAP-5 column
(GE Healthcare) to isolate conjugated antibody–ﬂuorophore complexes. All
ﬂuorophore-conjugated antibodies used were tested in order to keep the relative
levels of ﬂuorophore:antibody steady. For single color DAT labeling the Alexa405:
Alexa647:antibody ratio was [2,3]:[0.8–0.9]:1. For dual color dSTORM the
Alexa647:antibody or CF568:antibody ratio was [0.8–0.9]:1.
Immunocytochemistry. To assess the role of cholesterol and the cytoskeleton,
dopaminergic neurons or transfected CAD cells were treated with 5 mM methyl-β-
cyclodextrine (mβCD) for 30 min, 10 µg ml−1 nystatin for 20 min or 5 μg ml−1
cytochalasine D (CytD) for 2 h in cell media at 37 °C. To investigate the effect of
NMDA stimulation, the neurons were incubated for 9 min in imaging buffer with
or without 100 µM of the NMDA receptor antagonist AP5 before treatment for 5
min at room temperature with imaging buffer (control), 20 µM NMDA in imaging
buffer, or 100 µM AP5 and 20 µM NMDA in imaging buffer. Cells were ﬁxed using
3% (w/v) paraformaldehyde (PFA) in PBS (Electron Microscopy Sciences, Penn-
sylvania, USA) and incubated in 50 mM NH4Cl (Sigma) to quench background
ﬂuorescence. The sample was blocked and permeabilized in 5% (w/v) goat serum
(Gibco), 0.2% (w/v) Saponin (Sigma) in PBS, and subsequently incubated for 1 h in
in the appropriate primary antibody, DAT: rat anti-DAT (Millipore, mab369,
Massachusetts, USA) 1:200; TH: rabbit anti-TH antibody (Invitrogen, OOPA1-
04050) (1:1000), VMAT2: rabbit anti-VMAT2 antibody (1:2000) (a kind gift from
Dr. Gary Miller, Emory University)63 followed by secondary antibody 5 μg ml−1:
Donkey anti-Rat (Jackson ImmunoResearch, 712-005-150, Pennsylvania, USA) or
Donkey anti-Rabbit (Jackson ImmunoResearch, 711-005-152) conjugated with
indicated ﬂuorophores. The sample was post-ﬁxed in 3% PFA in PBS and stored
cold in PBS.
Striatal synaptosomal preparations. Coronal sections (1.5 mm) were used to
isolate the striatum from 9 to 11 weeks old mice. The tissue was homogenized in
homogenization buffer (0.32 M sucrose, 4 mM HEPES, pH 7.4) using a motor
driven Teﬂon pestle at 800 r.p.m. The membranes were isolated by a dual spin;
1000 × g for 10 min at 4 °C to remove cell nuclei and 16,000 × g for 20 min at 4 °C
to pellet the membranes and remove cytoplasma.
Sucrose gradient. CAD cells transiently expressing DAT, treated as explained
above, or striatal synaptosome preparations from 9 to 11 weeks old mice were lysed
in 1 ml lysis buffer (1% (w/v) Brij58 (w/v), protease inhibitor, and 0.2 mM PMSF in
the gradient buffer [25 mM HEPES, 150 mM NaCl, pH 7.4]) for 15 min on ice. A
14 ml continuous sucrose size gradient was made by mixing 1 ml sample in a 15 ml
centrifuge tube (Beckman Coulter, California, USA) with 1 ml sucrose (80% w/v) in
gradient buffer to create 2 ml with ﬁnal 40% (w/v) sucrose content. On top of this a
12 ml 35–15% (w/v) continuous gradient was layered using a SG15 gradient maker
(Hoefer, Massachusetts, USA). Subsequently the gradient was ultracentrifuged at
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100,000 × g for 18 h in a Beckman SW28.1 rotor head (Beckman Coulter, USA) and
fractionated into nine sections of 1.5 ml using a P1 pump. The samples were
electrophoresed using a 15 well, any kD, pre-cast gel (Biorad, California, USA),
transferred on to a PDVF membrane (Millipore, Massachusetts, USA) and devel-
oped with various primary antibodies; rat anti-DAT (Millipore, mab369) 1:1000,
rabbit anti-Flotillin1 (Sigma, Missouri, USA) 1:1000, mouse anti-transferrin
receptor (Invitrogen, 13-6800), and mouse-NaK ATPase (Abcam, ab7671, United
Kingdom) 1:250 in 5% (w/v) milk powder, 0.05% (w/v) Tween-20 in PBS. Sec-
ondary antibodies were HRP-conjugated goat anti-rat (Pierce, 31,470, Illinois,
USA), and donkey anti-rabbit (Pierce, 31,458) and goat anti-mouse (Thermo
Scientiﬁc, 31,430) all 1:1000, and signal developed with ECL prime western blotting
reagent (GE Helthcare, United Kingdom). Please see Supplementary Fig. 8 for
uncropped immunoblots.
Reversible biotinylation assay. Cells (400,000) transiently expressing DAT were
seeded in six well plates 1 day prior to the experiment. On the day of the
experiment, the cells were incubated for 30 min with 1.2 mg ml−1 sulfo-NHS-S-S-
biotin in PBS on ice and washed twice in ice-cold 100 mM glycine in PBS to
remove unbound sulfo-NHS-S-S-biotin. During the internalization period, the
samples were treated with mβCD or left untreated as described above. Two wells
were kept on ice and one well was incubated for 30 min at 37 °C in cell media
without FBS supplemented with 100 µg ml−1 leupeptin and 20 µM monensin. To
strip the biocytin from the surface all samples but the “total surface” sample were
incubated twice for 20 min in 100 mM MesNA, 0.2% bovine serum albumin, 50
mM Tris-HCl, pH 8.8, 100 mM NaCl, 1 mM EDTA and subsequently washed twice
in ice-cold PBS. Samples were lyzed and mixed for 20 min at 4 °C in lysis buffer
(25 mM Tris, pH 7.5, 100 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.2 mM
PMSF, protease inhibitor mixture (Roche Applied Science), and 5 mM N-ethyl-
maleimide) and afterwards centrifuged for 15 min at 16,000 × g. We collected “total
sample” from each sample and mixed with the same amount of 2× loading buffer
(1% SDS, 2.5% β-mercaptoethanol, and 100 mM dithiothreitol). We pulled down
the proteins labeled with bocytin over night at 4 °C using avidin beads and washed
the sampleds four times in lysis buffer. The samples werre centrifuged for 3 min at
3000 × g per wash. Each sample was mixed with 2× loading buffer and loaded on a
10% pre-cast gel (Bio-Rad), followed by western blotting and development as
described under sucrose gradient. We utilized a mouse HRP-conjugated anti-β-
actin antibody (Sigma, A3854) 1:20,000. Immunoreactivity was quantiﬁed using
ImageJ. Statistical signiﬁcance was determined by one-way ANOVA followed by
Bonferroni’s multiple comparisons test.
Internalization assay. Cultured dopaminergic neurons were used at 11–13 DIV.
DAT at the cell surface was labeled by washed the neurons once in ice-cold imaging
buffer, and incubate for 20 min with 20 nM JHC1-64 at 4 °C. The neurons were
subsequently washed once in 37 °C imaging buffer before incubation with control
or 5 mM mβCD in imaging buffer. After 30 min the cells were washed twice and
incubated for 30 min in the imaging buffer at 37 °C before imaging. The images
were thresholded uniformly. We manually deﬁned and measured the integrated
signal from total soma signal as well as the signal from the internalized fraction
alone for each image. We then calculated the amount of internalized DAT as the
percentage of the total soma signal.
Super-resolution setup. For super-resolution imaging, we used an ECLIPSE Ti-E
epiﬂuoresence/TIRF microscope (NIKON, Japan) equipped with 405 nm, 488 nm
561, and 647 nm lasers (Coherent, California, USA). All lasers are individually
shuttered and collected in a single ﬁber to the sample through a 1.49 NA, ×100,
apochromat TIRF oil objective (NIKON). For PALM imaging the activation and
excitation lasers light (401 and 488 nm, respectively) are reﬂected by a dichroic
mirror (zt 405/488/561, F68-410, AHF, Germany) and the emitted ﬂuorescence
from Dronpa is ﬁltered by a longpass (488 Longpass, F76-490, AHF) and a
bandpass ﬁlter (F47-525, AHF). For STORM imaging the activation and excitation
lasers (401 and 647 nm, respectively) are reﬂected by a dichroic mirror (z405/488/
561/647 rpc) and the emitted light from Alexa647 is ﬁltered by a 710/80 nm
bandpass ﬁlter (NIKON). For dual-color STORM we used a dichroic mirror with
the range 350–412, 485–490, 558–564, and 637–660 nm (97,335 QUAD C-
NSTORM C156921). The excitation light was ﬁltered at the wavelengths: 401± 24
nm, 488± 15 nm, 561± 15 nm, 647± 24 nm. The emitted light was ﬁltered at the
wavelengths: 425–475, 505–545, 578–625, and 664–787 nm, and secondly by an
extra ﬁlter to decrease noise (561 nm Longpass, Edge Basic, F76-561, AHF). Images
were recorded with an EM-CCD camera (iXon3 897, Andor, United Kingdom). To
minimize sample drift in the z-direction over time a motorized piezo stage con-
trolled by a near-infrared light-adjusted perfect focus system (NIKON) is applied
to the system.
PALM. For PALM imaging of Dronpa-DAT, we obtained 5000 consecutive frames
with a frame rate of 33 Hz to construct one image. The 488 nm excitation laser was
held constant, 0.4 kW cm−2, during the capture of the image while the 405 nm
activation laser was gradually increased to <0.1 kW cm−2. To assess the role of
cholesterol and the cytoskeleton, CAD cells transiently expressing Dronpa-DAT
were treated with mβCD or CytD as described above.
STORM. STORM or dSTORM imaging was performed in a buffer containing
β-mercaptoehtanol and an enzymatic oxygen scavenger system (10% (w/v) glucose,
1% (v/v) beta-mercaptoethanol, 50 mM Tris-HCl (pH 8), 10 mM NaCl, 34 μg ml−1
catalase, 28 μg ml−1 glucose oxidase), which increases photoswitching by generating
a long-lived off state for Alexa647 required for STORM. For single color STORM
imaging, the high intensity 647 nm excitation laser was held constant, 2.3 kW cm−2,
and the low intensity 405 nm activation laser was gradually increased to <0.1 kW
cm−2 during the experiment. 10,000 cycles of four consecutive frames (one acti-
vation frame and three consecutive imaging frames) were acquired with a cycle rate
of 56 Hz. For single color dSTORM imaging, super-resolution images were con-
structed from 5000 frames, where the sample was subject to constant high intensity
647 nm laser and incrementally increased low intensity 405 nm laser light. For
dual-color dSTORM imaging, we acquired 10,000 cycles of one frame of 561 nm
laser activation followed by one frame of 647 nm laser at 16 Hz per cycle. Shutters
regulated the light path in order to separate the light between the frames. The 561
nm and 647 nm lasers were held constant at 0.6 and 1.1 kW cm−2, respectively,
while a 405 nm laser was gradually increased to <0.1 kW cm−2 in order to gradually
transfer the reporter dyes from the dark state to an active state. For quantitative
single color STORM imaging we corrected for multiple detection of single events
by using an acquisition scheme of four frames in one image cycle: one activation
frame and three subsequent imaging frames and the built analysis in Nis-Elements
(NIKON N-STORM). We ﬁltered particles so only particles that showed up in the
ﬁrst imaging frame and were gone by the third imaging frame were ﬁtted as one
speciﬁc particle. Particles that appeared in other imaging frames or remained for
longer periods were not ﬁtted. Secondly, we removed any event appearing in the
same pixel plus-minus one pixel in both two dimensions in the consecutive image
cycle. For dSTORM imaging, we corrected for events occurring in consecutive
frames using the built-in tool in NIS-Elements (NIKON). This automated analysis
combines events maintained throughout several frames and combines these events
as one.
Super-resolution data analysis. Particles were ﬁtted using the built-in STORM
module in NIS-Elements (Nikon) using a least-squares ﬁtting methods to the raw
data. Particles appearing in more than one frame was removed from consecutive
frames and only counted once. For Dronpa (live-PALM) particles were only ﬁtted
when having an 8× signal-to-noise ratio and ﬁltered by having at least 200 photons.
For Alexa647 and CF568 (STORM) particles were required a 10× signal-to-noise
ratio and 1000 photons. The localization precision was calculated as described64
and the resolution was assessed using the LocAlization Microscopy Analyzer
(LAMA)65, 66. For PALM imaging of Dronpa-DAT the localization precision
was ~15 nm whereas we achieved a localization precision of ~ 7 nm for STORM
imaging (Alexa647). For STORM images, LAMA indicated a resolution of ~ 65 nm.
To correct for drift in the X/Y direction, we applied the built-in drift correction in
the analysis tool NIS-elements (NIKON). Using continuous bright particles as
ﬁducial markers this corrects for drift occurring in the sample due to slow temporal
acquisition.
Density-based clustering analysis of super-resolution data. For the cluster
analysis we used DBSCAN67. This density-based clustering algorithm searches for
clusters by looking for number of localizations within a circle deﬁned by its radius,
ε, and its center, p. If the area of the circle contains more than a minimum number
of points (MinPts), a new cluster with p as a core object is created. Thus, the
DBSCAN algorithm requires the deﬁnition of the two input parameters ε and
MinPts. The algorithm then subsequently tests all the localizations found in the
ﬁrst cluster for having MinPts within a radius, ε, and assigns them to the cluster,
and so forth. If a localization does not have MinPts within ε, this point is deﬁned
as a border point of the cluster. We carefully determined ε and MinPts. We chose
ε= 30 nm in order to achieve a search radius that would allow more than one DAT
protein with antibodies bound next to each other in the plasma membrane inside
the cluster. MinPts was chosen based on an evaluation of number of points in
smaller clusters in our images. For our super-resolution data we applied custom
routines and ﬂexible procedures for clustering (fpc) package for R. We ﬁltered
the images by removing the monomer fraction localization with (ε= 60 and
MinPts = 10). Secondly, we deﬁned the cluster fraction (ε= 30 and MinPts = 20)
and generated cluster maps and assigned single colors to the individual clusters.
For Dronpa-DAT data we deﬁned the cluster fraction of ε= 30 and MinPts = 5
(For nystatin experiments both control and nystatin treated cells were analyzed
with MinPts = 3.). We tested the values on our images to determine DBSCAN’s
ability to assign meaningful clusters. For the statistical analysis of the data we
applied either a student’s t-test or a one-way ANOVA combined with Bonferroni’s
post-test.
Cluster size was determined using custom written scripts. The cluster area was
identiﬁed by ﬁrst ﬁnding the convex hull of each cluster through Andrew’s
monotone chain convex hull algorithm. The area was calculated from the convex
hull localizations by Gauss’s area formula, also known as the shoelace algorithm or
the surveyor’s area formula68. Finally, the cluster sizes were ﬁtted using a
lognormal distribution in Matlab 2015a (Matlab, Mathworks).
Coordinate based co-localization analysis. For the co-localization analysis of the
dual-color DAT stainings, we used a coordinate based colocalization (CBC)
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analysis within the super-resolution quantiﬁcation tool, LAMA65, 66. This method
of analysis utilizes the coordinate information from each localization, rather than
the intensity of the signal, in order to determine how much a given biological signal
is distributed in reference to a separate biological signal, and vice versa. Each
localization is assigned a CBC value between −1 and 1 that is determined by the
distribution of localizations arising from the same source and from the compared
source. Final CBC values of 1 indicate that the localization is part of a heterogenous
group from the two populations. CBC values near 0 indicate that the localization is
in a homogenous group that is not near any localizations from the other popu-
lation. CBC values of −1 indicate that the localization is part of a homogenous
group of localizations that is in the vicinity of the other localization population.
This entire process was automated and completed through the LAMA toolkit66.
Nanocluster veriﬁcation. The validity of the nanocluster phenotype in the PALM
studies was conﬁrmed through the use of an analysis method published by
Baumgart et al.24. This approach requires a data set containing a large range
of expression levels in order to discern true clustering vs. cluster artifacts from
stochastic blinking. A cluster mask was ﬁrst applied to each image, where each
localization was used as the center for a Gaussian, and a threshold was applied to
identify a binary cluster mask. The Gaussians had a standard deviation of 80 nm
and were cut off at 40 nm from the center. These parameters were identiﬁed based
off visual inspection. A threshold of 2.5 was utilized to identify clusters, as
recommended in the publication of this method24. From each image, the relative
area covered by the cluster mask (η) and the normalized average density of loca-
lizations within the clusters (ρ/ρ0) were found, and compared in order to verify true
clustering. For comparison, the expected values for a random distribution, as found
by Baumgart et al., are given by the equation:
ρ=ρ0 ¼ 1þ 1:4η4: ð1Þ
Data positively deviating from the line for a random distribution indicates that
true nanoclusters are identiﬁed.
The validity of the nanocluster phenotype in the STORM studies was supported
by a nearest-neighbor analysis. Through an in-house written python script, the
localizations were organized into a KDTree with the use of the python library scipy.
spatial. The number of other localizations present within a 30 nm radius from each
localization was identiﬁed through this KDTree structure, and the values were
indexed with the coordinates of each localization. Images utilizing nearest-neighbor
analysis were constructed utilizing this number of neighbor value as the color index
and/or as the z axis value in order to represent the density of the localizations
within clusters.
Statistical analyses. Imaging experiments were in general carried out three times
on multiple cells (numbers indicated for each experiments) to ensure reproducible
effect sizes. Biochemical experiments were carried out at least three times to ensure
reproducibility. To avoid any bias and to further increase reproducibility samples
were purposely kept in random orders when performing stainings, treatments as
well as microscopy. Data were analyzed using unpaired, two-tailed t-tests, one-way
analysis of variance (ANOVA) or repeated measures two-way ANOVA, wherever
appropriate. Bonferroni’s post-hoc test was performed following signiﬁcance with
an ANOVA. We tested for variance in data showing that no signiﬁcant difference
was observed between groups compared in the statistical tests. Prism software was
used for statistical analysis (GraphPad Inc, Version 6, La Jolla, CA, USA). Data are
presented as means± s.e.m. Signiﬁcance level was set at P< 0.05.
Code availability. Custom written codes used for the data analysis can be found at:
https://github.com/GetherLab/Super-Resolution-Data-Analysis together with a
description. For the analysis we have used a combination of the two programs R
and Python. All parameters are explained above.
Data availability. The authors declare that all the data supporting the ﬁndings of
this work are available with the article and its Supplementary Information ﬁles and
available from the corresponding author upon reasonable request.
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